| Previous Close | 0.0029 |
| Open | 0.0027 |
| Bid | 0.0000 x 0 |
| Ask | 0.0000 x 0 |
| Day's Range | 0.0027 - 0.0034 |
| 52 Week Range | 0.0025 - 0.0202 |
| Volume | 552,345 |
| Avg. Volume | 2,821,424 |
| Market Cap | 123,465 |
| Beta (3Y Monthly) | -2.70 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.0010 |
| Earnings Date | Jun 13, 2019 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
TORONTO, June 13, 2019 (GLOBE NEWSWIRE) -- via NetworkWire -- Easton Pharmaceuticals Inc. (OTC: EAPH) (“Easton” or “the Company”) announces it has filed its quarterly report for the three months ended March 31, 2019, and provides several key updates on its business initiatives. In the first quarter of 2019, Easton Pharmaceuticals recorded revenues of $612,689 and turned from a loss to post net income of $7,878. Revenues were generated from the Company’s contract with a prominent developer to frame 150 new homes in Whitby, Ontario, Canada, under its newly created real estate development division.
TORONTO, ON / ACCESSWIRE / April 30, 2019 / Easton Pharmaceuticals, Inc. (OTC PINK: EAPH) executive management is pleased to announce the move of its corporate head office from Elm Street, Toronto, Ontario to Brockhouse Road, Toronto, Ontario. Easton confirms that with the acquisition of Supreme Sweets Inc. the management will be joining the Easton team at the Brockhouse Road facility and adding the extensive product line up to its growing product group within the Company's Food and Beverage operation. This move will allow Easton to oversee their Food & Beverage, Real Estate and Gaming all within the same physical premises.
TORONTO, ON / ACCESSWIRE / April 24, 2019 / Easton Pharmaceuticals, Inc. (the "Company" or "Easton") (OTC PINK: EAPH) is pleased to announce that it has now officially closed on its acquisition of a food processing company based in Toronto, Canada. Easton has completed its acquisition of Supreme Sweets Inc. and 2498411 Ontario Inc. (collectively the "Acquiree"), which includes all the tangible and intangible assets of the company such as equipment, intellectual property (patents, trade secrets, formulas, etc.) and client lists of both Supreme Sweets Inc. and 2498411 Ontario Inc. The purchase was completed with a combination of cash and Easton stock.
TORONTO, ON / ACCESSWIRE / April 12, 2019 / Easton Pharmaceuticals, Inc. (OTC PINK: EAPH) provides update on the closing of its agreement to acquire a commercial bakery with existing revenues and projected to reach over $20,000,000 within 12 months. Easton announced earlier this week that its legal counsel believed that all documents would be completed this week with signatures and exchange of documents. Easton is acquiring a revenue generating commercial bakery and food preparation company in Toronto, Ontario, Canada.
TORONTO, ON / ACCESSWIRE / April 8, 2019 / Easton Pharmaceuticals Inc. (OTC PINK: EAPH) provides update on the closing of its agreement to acquire a commercial bakery with existing revenues and projected to reach over $20,000,000 within 12 months. Easton announced earlier in March that it had signed a Definitive Agreement to acquire a commercial bakery and food preparation company with existing revenues and projected revenues in excess of $20,000,000 over the next 12 months. Easton's legal counsel believes that all documents will be completed this week with signatures and exchange of documents.
TORONTO, ON / ACCESSWIRE / April 2, 2019 / Easton Pharmaceuticals Inc. (OTC PINK: EAPH) Announces that is has signed a Joint Venture Agreement for the purchase and development of 9 townhomes in Welland, Ontario and provides update on its ongoing contract for the framing of 150 homes in Whitby, Ontario. Easton is pleased to have signed a joint venture agreement for the purchase and development of 9 townhomes in Welland, Ontario, which is less than 30 minutes from Niagara Falls, Canada. This will be the second development project the Company has commenced, after its acquisition of approximately 3 acres in Cobourg, Ontario, where Easton is converting an existing heritage mansion into 6 luxurious residential condominium units, that will generate $2 million in profit for the Company and is expected to generate over $30 million over 3 years with the development of approximately 42 residential units.
TORONTO, ON / ACCESSWIRE / March 27, 2019 / Easton Pharmaceuticals Inc. (OTC PINK: EAPH) announces that it has signed a Letter of Intent with a Licensed Producer of Medical Marijuana in Canada, whereby Easton will participate in the LP's expansion plans. In its ongoing efforts to diversify and enter into other lucrative sectors, Easton is pleased to announce that it has signed a Letter of Intent with a Canadian Licensed Producer of Cannabis, already in revenues from its cultivation and sales activities. Easton has been in discussions with this LP since January and has finally concluded an LOI whereby Easton, through its Development Division, will undertake the build-out of the LP's new Oil Extraction facility in exchange for an ownership interest in the LP.
Easton realized revenues of $378,589 USD during 2018, an increase in revenues over 145% from 2017. The Company's revenues primarily derived during the last 2 quarters from activities generated from its Georgina property, as well as from its construction contract to frame 150 new homes, through its Real Estate and Development Division. Easton's management announced last year that it would be entering into additional lucrative market segments that its directors have experience in.
TORONTO, ON / ACCESSWIRE / March 13, 2019 / Easton Pharmaceuticals Inc. (OTC PINK: EAPH) Provides Update on Its $2,600,000 CDN framing contract to build approximately 150 homes just outside of Toronto, Ontario, including an update on its development project to construct upto 42 new homes on an approximately 2.7 acres property it recently acquired in Cobourg, Ontario. Easton recently announced that it has entered into a $2,600,000 CDN framing contract and has commenced work on the framing of approximately 150 homes with a well-known prominent regional builder. Easton received approximately $275,000 CDN during its last quarter (October to December 2018) in payments from its framing contract of 150 homes and has received a further $300,000 CDN in payments for the months of January and February 2019 so far.
TORONTO, ON / ACCESSWIRE / March 11, 2019 / Easton Pharmaceuticals Inc. (OTC PINK: EAPH ) announces that it has commenced the set-up of a Cannabis Edibles division, pursuant to its acquisition of a commercial ...
CORAL GABLES, FL / ACCESSWIRE / March 5, 2019 / The marijuana stock market has largely benefited from the ability of states to enact their own cannabis legislation, resulting in the majority of U.S. states having some form of legalized cannabis usage. Despite states operating with autonomy in terms of cannabis legalization, there are still a considerable amount of states that have yet to get on board. As we continue to move through the month of March, as lawmakers advocate for favorable cannabis legislation, this will hopefully translate to investors taking interest in the cannabis industry.
In its ongoing efforts to diversify and enter other lucrative sectors and add value-added businesses to achieve consistent growing sales to coincide with its revenue-generating framing contract and its pharmaceutical / diagnostic division, Easton is pleased to have signed an agreement to acquire a Toronto based commercial bakery and food preparation company which manufactures white labeled food products for third party food companies and its own line of niche food product lines, sold in major grocery chains, as well as specialty coffee chains. The company has an R&D division with product development and has begun discussions with licensed producers of cannabis, as well as food chains in order to develop and supply cannabis edible products.
Easton recently announced that it has entered into a $2,600,000 CDN framing contract and has commenced work on the framing of approximately 150 homes with a well-known prominent regional builder. Easton can disclose that it has collected approximately $600,000 CDN in payments to date since operations commenced, of the $2,600,000 CDN contract. Easton has been presented with another building contract to construct up to 200 residential units in Welland, Ontario, Canada, which it is currently working on finalizing a definitive agreement on.
TORONTO, ON, Jan. 23, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Easton Pharmaceuticals Inc. (OTC: EAPH) announces completion of its financial statements with $200,000 in sales in its quarter ending September 30th and just over $200,000 in sales booked in its last quarter ending December 31, 2018. Easton is pleased to have achieved what it believes to be consistent sales through its various operations. Easton currently owns approximately 3 acres in Cobourg, Ontario, just 1 hour east of the City.
TORONTO, ON, Jan. 11, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – Easton Pharmaceuticals Inc. (OTC: EAPH) provides operational update on its $2,600,000 CDN framing contract to build approximately 150 homes just outside of Toronto, Ontario including possible new project. Easton recently announced that it has entered into a $2,600,000 CDN framing contract and has commenced work on the framing of approximately 150 homes with a well-known prominent regional builder. Easton can disclose that it has collected approximately $150,000 CDN in payments over the past 30 day period since operations commenced.
TORONTO, ON, Jan. 02, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Easton Pharmaceuticals Inc. (OTC: EAPH) Announces that it has closed on a Construction Agreement and has started operations on a $2,600,000 CDN framing contract to build approximately 150 homes just outside of Toronto, Ontario. As part of its plan to enter more lucrative market segments and become a more diversified company, Easton through the efforts of its director Vince Demasi, is pleased to announce that it has entered into an agreement to complete the framing of approximately 150 homes over the next four months with a contract value of $2,600,000 CDN. Easton through a subsidiary company has executed a contract with a well-known local home builder to complete the framing of approximately 150 homes just outside of Toronto, Ontario, Canada.
TORONTO, ON, Dec. 18, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Easton Pharmaceuticals Inc. (OTC: EAPH) announces that it has closed on an Agreement to acquire a Real Estate Development Project just outside of Toronto, Ontario with 3 year cumulative profits expected to exceed $30,000,000 Canadian. As part of its plan to enter more lucrative market segments, Easton is pleased to announce that it has now completed its purchase of a development property in Cobourg, Ontario, a growing lakefront community just 1 hour east of Toronto. The property is approximately 2.5 acres and is zoned for a multi-residential development to allow up-to 48 units.
TORONTO, ON, Dec. 12, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Easton Pharmaceuticals Inc. (OTC: EAPH) Provides Company update including Hotel Acquisition in Toronto, BAYER Distribution Agreement for Mexico, as well as the Casino and Hotel Resort acquisition in Greece. As previously announced, Easton through the efforts of its CEO, Evan Karras and his personal involvement with a hotel / development property / project, located in the heart of downtown Toronto, Canada, is currently in the process of affecting changes to the recently signed agreement and various terms which has resulted in a delay in its anticipated closing. Easton entered into an agreement to acquire a property which has had an operating boutique hotel in it in the heart of downtown Toronto, whereby Easton has renegotiated the debt on the property.